Your browser doesn't support javascript.
loading
High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors.
Engerud, H; Tangen, I L; Berg, A; Kusonmano, K; Halle, M K; Oyan, A M; Kalland, K H; Stefansson, I; Trovik, J; Salvesen, H B; Krakstad, C.
Afiliação
  • Engerud H; 1] Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
  • Tangen IL; 1] Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
  • Berg A; 1] Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
  • Kusonmano K; 1] Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway [3] Computational Biology Unit, University of Bergen, Bergen, Norway.
  • Halle MK; 1] Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
  • Oyan AM; 1] Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway [2] Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
  • Kalland KH; 1] Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway [2] Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
  • Stefansson I; Department of Pathology, Haukeland University Hospital, Bergen, Norway.
  • Trovik J; 1] Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
  • Salvesen HB; 1] Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
  • Krakstad C; 1] Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
Br J Cancer ; 111(1): 78-84, 2014 Jul 08.
Article em En | MEDLINE | ID: mdl-24853175
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fatores de Transcrição / Biomarcadores Tumorais / Neoplasias do Endométrio / Proteínas de Choque Térmico HSP90 / Proteínas de Ligação a DNA Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Noruega
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fatores de Transcrição / Biomarcadores Tumorais / Neoplasias do Endométrio / Proteínas de Choque Térmico HSP90 / Proteínas de Ligação a DNA Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Noruega